Clinical trial
Effect of Auryxia on ESA Utilization in ESRD Patients With High Ferritin & Low Transferrin Saturation: A Pilot Project
NCT03055598 is registered in ClinicalTrials.gov with Sreedhar Mandayam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Auryxia on ESA Utilization in ESRD Patients With High Ferritin & Low Transferrin Saturation: A Pilot Project
- Lead sponsor
- Sreedhar Mandayam
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- May 11, 2017
- Completion date
- February 29, 2020
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney diseases, end stage renal disease